Research
2019 Discovery of the Year presented to Dr. Zhijie “Jason” Liu
June 15, 2020
Zhijie “Jason” Liu, Ph.D., assistant professor of molecular medicine and CPRIT Scholar in Cancer Research, earned the 2019 Discovery of the Year Award from the Mays Cancer Center for his breast cancer research.
2019 Clinical Investigator of the Year award recognizes GI cancer expert
June 15, 2020
Medical Oncologist Sukeshi Patel Arora, M.D., was named the Mays Cancer Center’s 2019 Clinical Investigator of the Year for her work with gastrointestinal cancer patients.
Internationally known biochemist building world-class genome repair program
June 15, 2020
Renowned biochemist Patrick Sung, D.Phil., and his team are developing a nationally recognized genome repair program designed to create new therapeutics to treat difference types of cancer.
Researchers, physicians working together to develop new ways to fight liver cancer
June 15, 2020
Liver cancer tumors removed by surgeons are being studied by scientists with the goal of finding better ways to prevent, diagnose and treat hepatocellular carcinoma (HCC) in Hispanics in South Texas.
Clinical trial tests FDA-approved drug to treat diffuse large B-cell lymphoma
June 15, 2020
Ricardo Aguiar, M.D., Ph.D., professor of medicine and vice chief for research in the Division of Hematology and Medical Oncology, is conducting research with the goal of finding a cure for patients who are diagnosed with diffuse large B-cell lymphoma.
Research focused on improving lymphoma treatments for Hispanics
June 15, 2020
Enrique Diaz, M.D., director of the Lymphoma Program at the Mays Cancer Center, discovered that Hispanic Hodgkin’s lymphoma patients experience the same or better results from cancer treatment as Caucasian patients.
Cancer researcher relocates to lead early drug development at Mays Cancer Center
June 15, 2020
Cancer researcher Daruka Mahadevan, M.D., Ph.D., joins Mays Cancer Center and is leading early phase drug development. Dr. Mahadevan is concentrating on pancreatic cancer and lymphoma in his relocated lab.
Lung cancer tumors studied to discover new treatment, increase survival rate
June 15, 2020
Physician-scientist Josephine Taverna, M.D., is leading a multidisciplinary team performing advanced research with the goal of greatly increasing the survival rate for patients diagnosed with lung cancer.
Oncologist/investigator dedicates extensive career to drug development
June 14, 2020
While the Mays Cancer Center is dramatically increasing its early phase therapeutic development, John Sarantopoulos, M.D., has worked tirelessly researching next-generation cancer therapy since 2004.
Circle of Hope funds pilot project to improve survivors’ quality of life
June 14, 2020
A one-year pilot project is designed to prove the concept and initial effectiveness of a holistic, individualized yet structured approach to improve physical, mental and spiritual aspects of quality of life for survivors of all types of cancer.
FDA approves new drug to treat rare blood cancer myelofibrosis
June 14, 2020
Mays Cancer Center director is part of an international research team that developed a new drug to treat myelofibrosis, a rare blood cancer. The U.S. Food and Drug Administration approved the new drug.
Local clinician named 2019 MPN Hero for work on myeloproliferative neoplasms
June 14, 2020
CURE Media Group awarded a 2019 MPN Heroes award to Robyn Scherber, M.D., M.P.H., a nationally recognized clinician and hematologist, for her work in the field of rare blood cancers.